|
C14ORF145 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.945400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.312800E-01 |
| Normal-vs-Stage2 |
4.038600E-01 |
| Normal-vs-Stage3 |
9.485200E-01 |
| Normal-vs-Stage4 |
1.074200E-01 |
| Stage1-vs-Stage2 |
4.402400E-01 |
| Stage1-vs-Stage3 |
9.020000E-01 |
| Stage1-vs-Stage4 |
1.096560E-01 |
| Stage2-vs-Stage3 |
4.412400E-01 |
| Stage2-vs-Stage4 |
6.049000E-01 |
| Stage3-vs-Stage4 |
1.309760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.274600E-01 |
| Normal-vs-AfricanAmerican |
6.174800E-01 |
| Normal-vs-Asian |
1.987450E-01 |
| Caucasian-vs-AfricanAmerican |
2.778000E-01 |
| Caucasian-vs-Asian |
1.320810E-01 |
| AfricanAmerican-vs-Asian |
3.908400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.532200E-01 |
| Normal-vs-Female |
6.180200E-01 |
| Male-vs-Female |
6.591200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.633400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.794100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.486200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.118100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.605590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.890800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.319750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.284360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.560290E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.586390E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.205200E-01 |
| Normal-vs-Grade 2 |
5.114200E-01 |
| Normal-vs-Grade 3 |
8.697400E-01 |
| Normal-vs-Grade 4 |
5.636200E-02 |
| Grade 1-vs-Grade 2 |
7.131600E-01 |
| Grade 1-vs-Grade 3 |
4.743600E-01 |
| Grade 1-vs-Grade 4 |
3.279400E-01 |
| Grade 2-vs-Grade 3 |
3.407600E-01 |
| Grade 2-vs-Grade 4 |
9.864400E-02 |
| Grade 3-vs-Grade 4 |
4.106000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.370000E-01 |
| Normal-vs-ccB subtype |
2.330400E-01 |
| ccA subtype-vs-ccB subtype |
2.843600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.844200E-01 |
| Normal-vs-N1 |
1.927200E-01 |
| N0-vs-N1 |
1.622040E-01 |
|
|
